We further examined the metabolic effects of both SR4 and niclosamide in melanoma cells, specifically the AMPK-mTOR and MAPK signaling, since these pathways have been shown to be important mediators of melanoma growth and proliferation. This evidence concerns the gene MTOR and melanoma.